Figure 1
Figure 1. Distribution of mutations among patients with AML derived from a MPN. Pre-exisitng MPN diagnosis and cytogenetic risk category as defined by Slovak et al13 is listed as well.

Distribution of mutations among patients with AML derived from a MPN. Pre-exisitng MPN diagnosis and cytogenetic risk category as defined by Slovak et al13  is listed as well.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal